Dionysus Digital Health, Inc.

Dionysus is developing an epigenetic testing platform designed to predict and diagnose conditions like postpartum depression before symptoms manifest. The company's platform analyzes stress patterns and hormonal changes to help identify at-risk individuals early, which allows preventive care during pregnancy or shortly after childbirth, enabling healthcare providers to facilitate timely interventions like therapy, medication, or stress management strategies.